Kevin M. Picardat

Array ( [id] => 1338930 [patent_doc_number] => 06593459 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Synthetic glycosulfopeptides and methods of synthesis thereof' [patent_app_type] => B1 [patent_app_number] => 09/334013 [patent_app_country] => US [patent_app_date] => 1999-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 13612 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593459.pdf [firstpage_image] =>[orig_patent_app_number] => 09334013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416320 [patent_doc_number] => 06525175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Trypsin inhibitors with insecticidal properties obtained from Pentaclethra macroloba' [patent_app_type] => B1 [patent_app_number] => 09/322379 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11664 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525175.pdf [firstpage_image] =>[orig_patent_app_number] => 09322379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 779268 [patent_doc_number] => 06995136 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-07 [patent_title] => 'Peptide fragments of murine epidermal growth factor as laminin receptor targets' [patent_app_type] => utility [patent_app_number] => 09/673785 [patent_app_country] => US [patent_app_date] => 1999-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6224 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/995/06995136.pdf [firstpage_image] =>[orig_patent_app_number] => 09673785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1408022 [patent_doc_number] => 06528299 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Protease for activating clotting factor VII' [patent_app_type] => B1 [patent_app_number] => 09/295316 [patent_app_country] => US [patent_app_date] => 1999-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9501 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528299.pdf [firstpage_image] =>[orig_patent_app_number] => 09295316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 505263 [patent_doc_number] => 07202217 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-04-10 [patent_title] => 'Method for PR-39 peptide regulated stimulation of angiogenesis' [patent_app_type] => utility [patent_app_number] => 09/276868 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 23 [patent_no_of_words] => 9987 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202217.pdf [firstpage_image] =>[orig_patent_app_number] => 09276868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241225 [patent_doc_number] => 06683048 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Compounds and methods for stimulating gene expression and cellular differentiation' [patent_app_type] => B1 [patent_app_number] => 09/265107 [patent_app_country] => US [patent_app_date] => 1999-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 13643 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683048.pdf [firstpage_image] =>[orig_patent_app_number] => 09265107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1269697 [patent_doc_number] => 06653098 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Method of producing mouse and human endostatin' [patent_app_type] => B1 [patent_app_number] => 09/231077 [patent_app_country] => US [patent_app_date] => 1999-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 9453 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 236 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653098.pdf [firstpage_image] =>[orig_patent_app_number] => 09231077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306949 [patent_doc_number] => 06326473 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Pharmaceutical preparations' [patent_app_type] => 1 [patent_app_number] => 9/223178 [patent_app_country] => US [patent_app_date] => 1998-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6486 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326473.pdf [firstpage_image] =>[orig_patent_app_number] => 223178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699203 [patent_doc_number] => 07067485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'IGF-I composition and its use' [patent_app_type] => utility [patent_app_number] => 09/187661 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9051 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067485.pdf [firstpage_image] =>[orig_patent_app_number] => 09187661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889049 [patent_doc_number] => 20020013273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'METHOD FOR PRODUCING SUSTAINED-RELEASE FORMULATIONS' [patent_app_type] => new [patent_app_number] => 09/187780 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12159 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013273.pdf [firstpage_image] =>[orig_patent_app_number] => 09187780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1152979 [patent_doc_number] => 06767892 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-27 [patent_title] => 'Compositions providing for increased IGF-I solubility' [patent_app_type] => B1 [patent_app_number] => 09/188051 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7512 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/767/06767892.pdf [firstpage_image] =>[orig_patent_app_number] => 09188051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999811 [patent_doc_number] => 20020028482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'NIP45 HUMAN HOMOLOG' [patent_app_type] => new [patent_app_number] => 09/175254 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19373 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028482.pdf [firstpage_image] =>[orig_patent_app_number] => 09175254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 714549 [patent_doc_number] => 07052702 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-30 [patent_title] => 'Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics' [patent_app_type] => utility [patent_app_number] => 09/529130 [patent_app_country] => US [patent_app_date] => 1998-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 6401 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/052/07052702.pdf [firstpage_image] =>[orig_patent_app_number] => 09529130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601794 [patent_doc_number] => 06476193 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'NLK1 protein and NLK1 protein complexes' [patent_app_type] => B1 [patent_app_number] => 09/167206 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 15 [patent_no_of_words] => 52083 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476193.pdf [firstpage_image] =>[orig_patent_app_number] => 09167206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348145 [patent_doc_number] => 06579849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-17 [patent_title] => 'Antibiotic peptides from bovine milk' [patent_app_type] => B2 [patent_app_number] => 09/155203 [patent_app_country] => US [patent_app_date] => 1998-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 4291 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579849.pdf [firstpage_image] =>[orig_patent_app_number] => 09155203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062875 [patent_doc_number] => 06849593 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-01 [patent_title] => 'Bifidogenic peptides' [patent_app_type] => utility [patent_app_number] => 09/508095 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1846 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849593.pdf [firstpage_image] =>[orig_patent_app_number] => 09508095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419601 [patent_doc_number] => 06514937 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3' [patent_app_type] => B1 [patent_app_number] => 09/123217 [patent_app_country] => US [patent_app_date] => 1998-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11104 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514937.pdf [firstpage_image] =>[orig_patent_app_number] => 09123217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1329190 [patent_doc_number] => 06600029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Metabolic engineering of polyhydroxyalkanoate monomer synthases' [patent_app_type] => B1 [patent_app_number] => 09/091609 [patent_app_country] => US [patent_app_date] => 1998-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 34 [patent_no_of_words] => 32605 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/600/06600029.pdf [firstpage_image] =>[orig_patent_app_number] => 09091609 [rel_patent_id] =>[rel_patent_doc_number] =>)